ask="1.7900"
ask_size="200"
average_daily_volume="236968"
bid="1.4600"
bid_size="3000"
book_value="0.3390"
change="-0.0503"
change_from_200_day_moving_average="-0.2705"
change_from_50_day_moving_average="-0.1634"
change_from_52_week_high="-3.5903"
change_From_52_week_low="0.3997"
change_in_percent="-3.2244%"
close="1.5097"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-1.4870"
ebitda="-12.32M"
eps_estimate_current_year="-1.5800"
eps_estimate_next_quarter="-0.3600"
eps_estimate_next_year="-0.8800"
ex_dividend_date="N/A"
float_shares="3761000"
high="1.6300"
high_52_weeks="5.1000"
last_trade_date="1/17/2017"
last_trade_price="1.5097"
last_trade_size="150"
last_trade_time="3:59pm"
low="1.4810"
low_52_weeks="1.1100"
market_capitalization="14.47M"
moving_average_200_day="1.7802"
moving_average_50_day="1.6731"
name="Eyegate Pharmaceuticals
Inc."
notes="N/A"
one_year_target_price="10.0000"
open="1.5900"
pe_ratio="N/A"
peg_ratio="0.0000"
percent_change_from_200_day_moving_average="-15.1940%"
percent_change_from_50_day_moving_average="-9.7674%"
percent_change_from_52_week_high="-70.3980%"
percent_change_from_52_week_low="+36.0090%"
previous_close="1.5600"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="4.6018"
price_per_sales="29.3828"
revenue="508889.00"
shares_outstanding="9585000"
short_ratio="0.4500"
stock_exchange="NCM"
symbol="EYEG"
volume="52497"
weeks_range_52="1.1100 - 5.1000"
